Inhibition of FAO by overexpressing HES1 alleviated SIRT3-induced chemoresistance in AML, suggesting that HES1 may be one of the key tumor suppressors outside the mitochondria targeted by SIRT3. This evidence concerns the gene HES1 and acute myeloid leukemia.